Cite
Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy
MLA
Man Charurat, et al. “Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy.” The Journal of Infectious Diseases, vol. 221, Aug. 2019, pp. 102–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ca17acbeb1ce43f9f37d07dd17fbb4e3&authtype=sso&custid=ns315887.
APA
Man Charurat, Benjamin Emmanuel, Laurence S. Magder, Thomas R. O’Brien, Ludmila Prokunina-Olsson, Shyam Kottilil, Samer S. El-Kamary, Colleen Hadigan, Cheryl Chairez, Kristen A Stafford, Henry Masur, & Mary Ann McLaughlin. (2019). Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy. The Journal of Infectious Diseases, 221, 102–109.
Chicago
Man Charurat, Benjamin Emmanuel, Laurence S. Magder, Thomas R. O’Brien, Ludmila Prokunina-Olsson, Shyam Kottilil, Samer S. El-Kamary, et al. 2019. “Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-ΔG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy.” The Journal of Infectious Diseases 221 (August): 102–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ca17acbeb1ce43f9f37d07dd17fbb4e3&authtype=sso&custid=ns315887.